Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' PAUWELS PJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 88 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wurch, T; Pauwels, PJ
      Analytical pharmacology of G protein-coupled receptors by stoichiometric expression of the receptor and G alpha protein subunits

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    2. Robinet, EA; Wurch, T; Pauwels, PJ
      Different regulation of RGS2 mRNA by haloperidol and clozapine

      NEUROREPORT
    3. Dupuis, DS; Pauwels, PJ
      Diversity of signalling by G protein-coupled receptors

      M S-MEDECINE SCIENCES
    4. Robinet, EA; Geurts, M; Maloteaux, JM; Pauwels, PJ
      Chronic treatment with certain antipsychotic drugs preserves upregulation of regulator of G-protein signalling 2 mRNA in rat striatum as opposed to c-fos mRNA

      NEUROSCIENCE LETTERS
    5. Dupuis, DS; Wurch, T; Tardif, S; Colpaert, FC; Pauwels, PJ
      Modulation of 5-HT1A receptor activation by its interaction with wild-typeand mutant G(alpha i3) proteins

      NEUROPHARMACOLOGY
    6. Pauwels, PJ; Wurch, T; Tardif, S; Finana, F; Colpaert, FC
      Analysis of ligand activation of alpha(2)-adrenoceptor subtypes under conditions of equal G alpha protein stoichiometry

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    7. Wurch, T; Okuda, J; Pauwels, PJ
      Reciprocal modulation of alpha(2A)-adrenoceptor and G(alpha o) protein states as determined by carboxy-terminal mutagenesis of a G(alpha o) protein

      MOLECULAR PHARMACOLOGY
    8. Pauwels, PJ; Finana, F; Tardif, S; Wurch, T; Colpaert, FC
      Dynamic dopamine-antagonist interactions at recombinant human dopamine D-2short receptor: Dopamine-bound versus antagonist-bound receptor states

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    9. Wurch, T; Matsumoto, A; Pauwels, PJ
      Agonist-independent and -dependent oligomerization of doparnine D-2 receptors by fusion to fluorescent proteins

      FEBS LETTERS
    10. Koek, W; Vacher, B; Cosi, C; Assie, MB; Patoiseau, JF; Pauwels, PJ; Colpaert, FC
      5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential

      EUROPEAN JOURNAL OF PHARMACOLOGY
    11. Pauwels, PJ; Tardif, S; Wurch, T; Colpaert, FC
      Real-time analysis of dopamine: antagonist interactions at recombinant human D-2long receptor upon modulation of its activation state

      BRITISH JOURNAL OF PHARMACOLOGY
    12. Bhalla, P; Sharma, HS; Ma, XQ; Wurch, T; Pauwels, PJ; Saxena, PR
      Molecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT1B receptor

      BRITISH JOURNAL OF PHARMACOLOGY
    13. Pauwels, PJ; Tardif, S; Colpaert, FC
      Differential signalling of both wild-type and Thr(343) Arg dopamine D-2short receptor by partial agonists in a G-protein-dependent manner

      BIOCHEMICAL PHARMACOLOGY
    14. Pauwels, PJ; Tardif, S; Colpaert, FC; Wurch, T
      Modulation of ligand responses by coupling of alpha(2A)-adrenoceptors to diverse G(alpha)-proteins

      BIOCHEMICAL PHARMACOLOGY
    15. Wurch, T; Lestienne, F; Pauwels, PJ
      Optimisation of overlap extension PCR-based mutagenesis of a GC-rich DNA template: application to the human alpha(2C)-adrenoceptor cDNA

      BIOTECHNOLOGY LETTERS
    16. Pauwels, PJ; Colpaert, FC
      Heterogeneous ligand-mediated Ca++ responses at wt and mutant alpha(2A)-adrenoceptors suggest multiple ligand activation binding sites at the alpha(2A)-adrenoceptor

      NEUROPHARMACOLOGY
    17. Pauwels, PJ; Finana, F; Tardif, S; Colpaert, FC; Wurch, T
      Agonist efficacy at the alpha(2A)-adrenoceptor : G(alpha 15) fusion protein: an analysis based on Ca2+ responses

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    18. Pauwels, PJ; Tardif, S; Wurch, T; Colpaert, FC
      Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and G(alpha o) protein coexpression: Evidence for inverse agonism

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    19. Wurch, T; Pauwels, PJ
      Coupling of canine serotonin 5-HT1B and 5-HT1D receptor subtypes to the formation of inositol phosphates by dual interactions with endogenous G(i/o) and recombinant G(alpha 15) proteins

      JOURNAL OF NEUROCHEMISTRY
    20. Pauwels, PJ; Tardif, S; Finana, F; Wurch, T; Colpaert, FC
      Ligand-receptor interactions as controlled by wild-type and mutant Thr(370)Lys alpha(2B)-adrenoceptor-G(alpha 15) fusion proteins

      JOURNAL OF NEUROCHEMISTRY
    21. Mayer, P; Brunel, P; Chaplain, C; Piedecoq, C; Calmel, F; Schambel, P; Chopin, P; Wurch, T; Pauwels, PJ; Marien, M; Vidaluc, JL; Imbert, T
      New substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with alpha(2)-adrenoceptor antagonist activity

      JOURNAL OF MEDICINAL CHEMISTRY
    22. Le Grand, B; Panissie, A; Perez, M; Pauwels, PJ; John, GW
      Zolmitriptan stimulates a Ca2+-dependent K+ current in C6 glioma cells stably expressing recombinant human 5-HT1B receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    23. Pauwels, PJ; Colpaert, FC
      Partial to complete antagonism by putative antagonists at the wild-type alpha(2C)-adrenoceptor based on kinetic analyses of agonist : antagonist interactions

      BRITISH JOURNAL OF PHARMACOLOGY
    24. Bhalla, P; Sharma, HS; Wurch, T; Pauwels, PJ; Saxena, PR
      Molecular cloning, sequence analysis and pharmacological properties of theporcine 5-HT1D receptor

      BRITISH JOURNAL OF PHARMACOLOGY
    25. Pauwels, PJ; Colpaert, FC
      Disparate ligand-mediated Ca2+ responses by wild-type, mutant Ser(200)Ala and Ser(204)Ala alpha(2A)-adrenoceptor: G(alpha 15) fusion proteins: evidence for multiple ligand-activation binding sites

      BRITISH JOURNAL OF PHARMACOLOGY
    26. Pauwels, PJ
      Diverse signalling by 5-hydroxytryptamine (5-HT) receptors

      BIOCHEMICAL PHARMACOLOGY
    27. Wurch, T; Palmier, C; Pauwels, PJ
      Induction of a high-affinity ketanserin binding site at the 5-hydroxytryptamine(1B) receptor by modification of its carboxy-terminal intracellular portion

      BIOCHEMICAL PHARMACOLOGY
    28. Rauly, I; Ailhaud, MC; Wurch, T; Pauwels, PJ
      alpha(2A)-adrenoceptor: G(alpha i1) protein-mediated pertussis toxin-resistant attenuation of G(s) coupling to the cyclic AMP pathway

      BIOCHEMICAL PHARMACOLOGY
    29. Dupuis, DS; Pauwels, PJ; Radu, D; Hall, H
      Autoradiographic studies of 5-HT1A-receptor-stimulated [S-35]GTP gamma S-binding responses in the human and monkey brain

      EUROPEAN JOURNAL OF NEUROSCIENCE
    30. Pauwels, PJ; John, GW
      Present and future of 5-HT receptor agonists as antimigraine drugs

      CLINICAL NEUROPHARMACOLOGY
    31. Pauwels, PJ; Gouble, A; Wurch, T
      Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series ofmutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(0)alpha protein interactions

      BIOCHEMICAL JOURNAL
    32. Dupuis, DS; Perez, M; Halazy, S; Colpaert, FC; Pauwels, PJ
      Magnitude of 5-HT1B and 5-HT1A receptor activation in guinea-pig and rat brain: evidence from sumatriptan dimer-mediated [S-35]GTP gamma S binding responses

      MOLECULAR BRAIN RESEARCH
    33. Dupuis, DS; Tardif, S; Wurch, T; Colpaert, FC; Pauwels, PJ
      Modulation of 5-MT1A receptor signalling by point-mutation of cysteine(351) in the rat G(alpha o) protein

      NEUROPHARMACOLOGY
    34. John, GW; Pauwels, PJ; Perez, M; Halazy, S; Le Grand, B; Verscheure, Y; Valentin, JP; Palmier, C; Wurch, T; Chopin, P; Marien, M; Kleven, MS; Koek, W; Assie, MB; Carilla-Durand, E; Tarayre, JP; Colpaert, FC
      F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    35. Wurch, T; Colpaert, FC; Pauwels, PJ
      G-protein activation by putative antagonists at mutant Thr(373)Lys alpha(2A) adrenergic receptors

      BRITISH JOURNAL OF PHARMACOLOGY
    36. PAUWELS PJ
      NA-DEPENDENT METABOLIC COUPLING UPON 5-HT1B RECEPTOR ACTIVATION BY SUMATRIPTAN AND RELATED AGONISTS()

      Receptors & channels
    37. LAMOTHE M; PAUWELS PJ; LEBORGNE M; HALAZY S
      SYNTHESIS OF NEW BENZOTHIENYLPIPERAZINE DERIVATIVES AND THEIR CHARACTERIZATION AT BOTH 5HT(1A) AND 5HT(1B) RECEPTOR-SITES

      Medicinal chemistry research
    38. BARF T; WIKSTROM H; PAUWELS PJ; PALMIER C; TARDIF S; LUNDMARK M; SUNDELL S
      5-(SULFONYL)OXY-TRYPTAMINES AND ETHYLAMINO SIDE-CHAIN RESTRICTED DERIVATIVES - STRUCTURE-AFFINITY RELATIONSHIPS FOR H5-HT1B AND H5-HT1D RECEPTORS

      Bioorganic & medicinal chemistry
    39. PEREZ M; PAUWELS PJ; FOURRIER C; CHOPIN P; VALENTIN JP; JOHN GW; MARIEN M; HALAZY S
      DIMERIZATION OF SUMATRIPTAN AS AN EFFICIENT WAY TO DESIGN A POTENT, CENTRALLY AND ORALLY-ACTIVE 5-HT1B AGONIST

      Bioorganic & medicinal chemistry letters
    40. PEREZ M; JORANDLEBRUN C; PAUWELS PJ; PALLARD I; HALAZY S
      DIMERS OF 5HT(1) LIGANDS PREFERENTIALLY BIND TO 5HT(1B 1D) RECEPTOR SUBTYPES/

      Bioorganic & medicinal chemistry letters
    41. Perez, M; Pauwels, PJ; Pallard-Sigogneau, I; Fourrier, C; Chopin, P; Palmier, C; Colovray, V; Halazy, S
      Design and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    42. WURCH T; LESTIENNE F; PAUWELS PJ
      A MODIFIED OVERLAP EXTENSION PCR METHOD TO CREATE CHIMERIC GENES IN THE ABSENCE OF RESTRICTION ENZYMES

      Biotechnology techniques
    43. Pauwels, PJ; Wurch, T
      Amino acid domains involved in constitutive activation of G-protein-coupled receptors - Review

      MOLECULAR NEUROBIOLOGY
    44. WURCH T; PAUWELS PJ
      PREDOMINANT EXPRESSION OF SEROTONIN 5-HT1B RECEPTOR MESSENGER-RNA IN PIG CORONARY-ARTERY

      Neuroscience research communications
    45. PAUWELS PJ; DUPUIS DS; PEREZ M; HALAZY S
      DIMERIZATION OF 8-OH-DPAT INCREASES ACTIVITY AT SEROTONIN 5-HT1A RECEPTORS

      Naunyn-Schmiedeberg's archives of pharmacology
    46. ROUSSELLE JC; PLANTEFOL M; FILLION MP; MASSOT O; PAUWELS PJ; FILLION G
      SPECIFIC INTERACTION OF 5-HT-MODULINE WITH HUMAN 5-HT1B AS WELL AS 5-HT1D RECEPTORS EXPRESSED IN TRANSFECTED CULTURED-CELLS

      Naunyn-Schmiedeberg's archives of pharmacology
    47. WURCH T; PALMIER C; RAULY I; COLPAERT FC; PAUWELS PJ
      MUTATION OF THR373 IN THE 3RD INTRACELLULAR LOOP OF THE HUMAN ALPHA(2A)-ADRENERGIC RECEPTOR PROMOTES PARTIAL AGONIST ACTIVITY FROM ANTAGONISTS

      Naunyn-Schmiedeberg's archives of pharmacology
    48. JOHN GW; VALENTIN JP; LEGRAND B; BONNAFOUS R; PANISSIE A; VIE B; PEREZ M; HALAZY S; PAUWELS PJ; COLPAERT FC
      IN-VITRO VASCULAR AND NEURONAL ACTIONS OF F-11356, A NOVEL HIGH EFFICACY 5HT(1B D) RECEPTOR AGONIST, IN MODELS RELEVANT TO MIGRAINE/

      Naunyn-Schmiedeberg's archives of pharmacology
    49. PAUWELS PJ; PALMIER C; TARDIF S; WURCH T; PEREZ M; CARILLADURAND E; JOHN GW; HALAZY S; COLPAERT FC
      F-11356, A NEW 5-HT DERIVATIVE, WITH SELECTIVE, POTENT AND HIGH EFFICACY AGONIST PROPERTIES AT 5-HT1B D RECEPTORS/

      Naunyn-Schmiedeberg's archives of pharmacology
    50. PAUWELS PJ; PALMIER C; DUPUIS DS; COLPAERT FC
      INTERACTION OF 5 HT1B D LIGANDS WITH RECOMBINANT-H 5-HT1A RECEPTORS -INTRINSIC ACTIVITY AND MODULATION BY G-PROTEIN ACTIVATION STATE/

      Naunyn-Schmiedeberg's archives of pharmacology
    51. Le Grand, B; Panissie, A; Pauwels, PJ; John, GW
      Activation of recombinant h 5-HT1B and h 5-HT1D receptors stably expressedin C6 glioma cells produces increases in Ca2+-dependent K+ current

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    52. Wurch, T; Colpaert, FC; Pauwels, PJ
      Chimeric receptor analysis of the ketanserin binding site in the human 5-hydroxytryptamine(1D) receptor: Importance of the second extracellular loop and fifth transmembrane domain in antagonist binding

      MOLECULAR PHARMACOLOGY
    53. KOEK W; PATOISEAU JF; ASSIE MB; COSI C; KLEVEN MS; DUPONTPASSELAIGUE E; CARILLADURAND E; PALMIER C; VALENTIN JP; JOHN G; PAUWELS PJ; TARAYRE JP; COLPAERT FC
      F-11440, A POTENT, SELECTIVE, HIGH EFFICACY 5-HT1A RECEPTOR AGONIST WITH MARKED ANXIOLYTIC AND ANTIDEPRESSANT POTENTIAL

      The Journal of pharmacology and experimental therapeutics
    54. DUPUIS DS; PALMIER C; COLPAERT FC; PAUWELS PJ
      AUTORADIOGRAPHY OF SEROTONIN 5-HT1A RECEPTOR-ACTIVATED G-PROTEINS IN GUINEA-PIG BRAIN SECTIONS BY AGONIST-STIMULATED [S-35] GTP-GAMMA-S BINDING

      Journal of neurochemistry
    55. DUPUIS DS; COLPAERT FC; PAUWELS PJ
      G-PROTEIN ACTIVATION AT 5-HT1A RECEPTORS BY THE 5-HT(1F) LIGAND LY334370 IN GUINEA-PIG BRAIN SECTIONS AND RECOMBINANT CELL-LINES

      British Journal of Pharmacology
    56. PAUWELS PJ; WURCH T; PALMIER C; COLPAERT FC
      PHARMACOLOGICAL ANALYSIS OF G-PROTEIN ACTIVATION MEDIATED BY GUINEA-PIG RECOMBINANT 5-HT1B RECEPTORS IN C6-GLIAL CELLS - SIMILARITIES WITH THE HUMAN 5-HT1B RECEPTOR

      British Journal of Pharmacology
    57. AMOUREUX MC; VANGOOL D; HERRERO MT; DOM R; COLPAERT FC; PAUWELS PJ
      REGULATION OF METALLOTHIONEIN-III (GIF) MESSENGER-RNA IN THE BRAIN OFPATIENTS WITH ALZHEIMER-DISEASE IS NOT IMPAIRED

      Molecular and chemical neuropathology
    58. JORANDLEBRUN C; PAUWELS PJ; PALMIER C; CHOPIN P; MORET C; MARIEN M; HALAZY S
      ARYLPIPERAZIDE DERIVATIVES OF PHENYLPIPERAZINES AS A NEW CLASS OF POTENT AND SELECTIVE 5-HT1B RECEPTOR ANTAGONISTS

      Bioorganic & medicinal chemistry letters
    59. PAUWELS PJ
      COMPETITIVE AND SILENT ANTAGONISM OF RECOMBINANT 5-HT1B RECEPTORS BY AMILORIDE

      General pharmacology
    60. PAUWELS PJ
      5-HT1B D RECEPTOR ANTAGONISTS

      General pharmacology
    61. PEREZ M; AYERBE N; FOURRIER C; SIGOGNEAU I; PAUWELS PJ; PALMIER C; JOHN GW; VALENTIN JP; HALAZY S
      SYNTHESIS, BINDING-AFFINITY AND INTRINSIC ACTIVITY OF NEW ANILIDE DERIVATIVES OF SEROTONIN AT HUMAN 5-HT1D RECEPTORS

      European journal of medicinal chemistry
    62. PAUWELS PJ; TARDIF S; PALMIER C; WURCH T; COLPAERT FC
      HOW EFFICACIOUS ARE 5-HT1B D RECEPTOR LIGANDS - AN ANSWER FROM GTP-GAMMA-S BINDING-STUDIES WITH STABLY TRANSFECTED C6-GLIAL CELL-LINES/

      Neuropharmacology
    63. PAUWELS PJ; TARDIF S; WURCH T; COLPAERT FC
      STIMULATED [S-35] GTP-GAMMA-S BINDING BY 5-HT1A RECEPTOR AGONISTS IN RECOMBINANT CELL-LINES - MODULATION OF APPARENT EFFICACY BY G-PROTEIN ACTIVATION STATE

      Naunyn-Schmiedeberg's archives of pharmacology
    64. WURCH T; PALMIER C; COLPAERT FC; PAUWELS PJ
      SEQUENCE AND FUNCTIONAL-ANALYSIS OF CLONED GUINEA-PIG AND RAT SEROTONIN 5-HT1D RECEPTORS, COMMON PHARMACOLOGICAL FEATURES WITHIN THE 5-HT1DRECEPTOR SUBFAMILY

      Journal of neurochemistry
    65. JORANDLEBRUN C; PAUWELS PJ; PALMIER C; MORET C; CHOPIN P; PEREZ M; MARIEN M; HALAZY S
      5-HT1B RECEPTOR ANTAGONIST PROPERTIES OF NOVEL ARYLPIPERAZIDE DERIVATIVES OF 1-NAPHTHYLPIPERAZINE

      Journal of medicinal chemistry
    66. LAMOTHE M; PAUWELS PJ; BELLIARD K; SCHAMBEL P; HALAZY S
      DIFFERENTIATION BETWEEN PARTIAL AGONISTS AND NEUTRAL 5-HT1B ANTAGONISTS BY CHEMICAL MODULATION OF PYL]-4-HYDROXY-N-[4-(PYRIDIN-4-YL)PHENYL]BENZAMIDE (GR-55562)

      Journal of medicinal chemistry
    67. LEGRAND B; PAUWELS PJ; PANISSIE A; JOHN GW
      RECOMBINANT H5-HT1B AND H5-HT1D RECEPTORS STABLY EXPRESSED IN C6 GLIOMA-CELLS ARE COUPLED TO CALCIUM-DEPENDENT POTASSIUM CHANNELS

      British Journal of Pharmacology
    68. WURCH T; PALMIER C; COLPAERT FC; PAUWELS PJ
      RECOMBINANT SAPHENOUS-VEIN 5-HT1B RECEPTORS OF THE RABBIT - COMPARATIVE PHARMACOLOGY WITH HUMAN 5-HT1B RECEPTORS

      British Journal of Pharmacology
    69. WURCH T; CHASTAGNIER C; PALMIER C; COLPAERT FC; PAUWELS PJ
      A 413 BP REGION UPSTREAM THE HUMAN 5-HT1A RECEPTOR GENE IS SUFFICIENTFOR ITS IN-VITRO EXPRESSION

      Neuroscience research communications
    70. WURCH T; CATHALA C; PALMIER C; VALENTIN JP; JOHN GW; COLPAERT FC; PAUWELS PJ
      MOLECULAR-CLONING AND IDENTIFICATION OF A RABBIT SAPHENOUS-VEIN 5-HT1D-BETA RECEPTOR GENE

      Neuroscience research communications
    71. PAUWELS PJ; WURCH T; PALMIER C; COLPAERT FC
      PROMOTION OF CELL-GROWTH BY STIMULATION OF CLONED HUMAN 5-HT1D RECEPTOR-SITES IN TRANSFECTED C6-GLIAL CELLS IS HIGHLY SENSITIVE TO INTRINSIC ACTIVITY AT 5-HT1D RECEPTORS

      Naunyn-Schmiedeberg's archives of pharmacology
    72. PAUWELS PJ; PALMIER C; WURCH T; COLPAERT FC
      PHARMACOLOGY OF CLONED HUMAN 5-HT1D RECEPTOR-MEDIATED FUNCTIONAL-RESPONSES IN STABLY TRANSFECTED RAT C6-GLIAL CELL-LINES - FURTHER EVIDENCEDIFFERENTIATING HUMAN 5-HT1D AND 5-HT1B RECEPTORS

      Naunyn-Schmiedeberg's archives of pharmacology
    73. PAUWELS PJ; WURCH T; AMOUREUX MC; PALMIER C; COLPAERT FC
      STIMULATION OF CLONED HUMAN SEROTONIN 5-HT1D-BETA RECEPTOR-SITES IN STABLY TRANSFECTED C6 GLIAL-CELLS PROMOTES CELL-GROWTH

      Journal of neurochemistry
    74. HALAZY S; PEREZ M; FOURRIER C; PALLARD I; PAUWELS PJ; PALMIER C; JOHN GW; VALENTIN JP; BONNAFOUS R; MARTINEZ J
      SEROTONIN DIMERS - APPLICATION OF THE BIVALENT LIGAND APPROACH TO THEDESIGN OF NEW POTENT AND SELECTIVE 5-HT1B 1D AGONISTS/

      Journal of medicinal chemistry
    75. PAUWELS PJ; COLPAERT FC
      STEREOSELECTIVITY OF 8-OH-DPAT ENANTIOMERS AT CLONED HUMAN 5-HT1D RECEPTOR-SITES

      European journal of pharmacology
    76. PAUWELS PJ; COLPAERT FC
      SELECTIVE ANTAGONISM OF HUMAN 5-HT1D AND 5-HT1B RECEPTOR-MEDIATED RESPONSES IN STABLY TRANSFECTED C6-GLIAL CELLS BY KETANSERIN AND GR-127,935

      European journal of pharmacology
    77. PAUWELS PJ; PALMIER C
      FUNCTIONAL-EFFECTS OF THE 5-HT1D RECEPTOR ANTAGONIST GR-127,935 AT HUMAN 5-HT1D-ALPHA, 5-HT1D-BETA, 5-HT1A AND OPOSSUM 5-HT1B RECEPTORS

      European journal of pharmacology. Molecular pharmacology section
    78. AMOUREUX MC; WURCH T; PAUWELS PJ
      EXPRESSION OF HUMAN METALLOTHIONEIN-III CONFERS PROTECTION AGAINST SERUM-FREE EXPOSURE OF STABLY TRANSFECTED CHINESE-HAMSTER OVARY CHO-K1 CELLS

      Neuroscience letters
    79. PAUWELS PJ; COLPAERT FC
      THE 5-HT1D RECEPTOR ANTAGONIST GR-127,935 IS AN AGONIST AT CLONED HUMAN 5-HT1D-ALPHA RECEPTOR-SITES

      Neuropharmacology
    80. PEREZ M; FOURRIER C; SIGOGNEAU I; PAUWELS PJ; PALMIER C; JOHN GW; VALENTIN JP; HALAZY S
      SYNTHESIS AND SEROTONERGIC ACTIVITY OF ARYLPIPERAZIDE DERIVATIVES OF SEROTONIN - POTENT AGONISTS FOR 5-HT1D RECEPTORS

      Journal of medicinal chemistry
    81. PAUWELS PJ; COLPAERT FC
      DIFFERENTIATION BETWEEN PARTIAL AND SILENT 5-HT1D-BETA RECEPTOR ANTAGONISTS USING RAT C6-GLIAL AND CHINESE-HAMSTER OVARY CELL-LINES PERMANENTLY TRANSFECTED WITH A CLONED HUMAN 5-HT1D-BETA RECEPTOR GENE

      Biochemical pharmacology
    82. AMOUREUX MC; WURCH T; PAUWELS PJ
      MODULATION OF METALLOTHIONEIN-III MESSENGER-RNA CONTENT AND GROWTH-RATE OF RAT C6-GLIAL CELLS BY TRANSFECTION WITH HUMAN 5-HT1D RECEPTOR GENES

      Biochemical and biophysical research communications
    83. PAUWELS PJ; PALMIER C
      INHIBITION BY 5-HT OF FORSKOLIN-INDUCED CAMP FORMATION IN THE RENAL OPOSSUM EPITHELIAL-CELL LINE OK - MEDIATION OF A 5-HT1B LIKE RECEPTOR AND ANTAGONISM BY METHIOTHEPIN

      Neuropharmacology
    84. PAUWELS PJ; PALMIER C
      DIFFERENTIAL FUNCTIONAL-ACTIVITY OF 5-HYDROXYTRYPTAMINE RECEPTOR LIGANDS AND BETA-ADRENERGIC-RECEPTOR ANTAGONISTS AT 5-HYDROXYTRYPTAMINE(1B) RECEPTOR-SITES IN CHINESE-HAMSTER LUNG FIBROBLASTS AND OPOSSUM RENALEPITHELIAL-CELLS

      The Journal of pharmacology and experimental therapeutics
    85. PAUWELS PJ; VANGOOL D
      IMPROVED SURVIVAL OF RAT-BRAIN NEURONS IN CULTURE BY FRONTAL-CORTEX BRAIN EXTRACT AND CEREBROSPINAL-FLUID OF PATIENTS WITH SENILE DEMENTIA OF ALZHEIMERS TYPE

      Journal of neurochemistry
    86. PAUWELS PJ; VANASSOUW HP; DERYCK M; LEYSEN JE; DOM R; VANGOOL D
      TOWARDS AND IMPROVED SURVIVAL OF RAT-BRAIN NEURONS IN CULTURE BY CEREBROSPINAL-FLUID OF PATIENTS WITH SENILE DEMENTIA OF ALZHEIMERS TYPE

      Brain research
    87. PAUWELS PJ; PALMIER C; BRILEY M
      IDENTIFICATION OF 5-HYDROXYTRYPTAMINE(10) BINDING-SITES IN SHEEP CAUDATE-NUCLEUS MEMBRANES

      Biochemical pharmacology
    88. LEYSEN JE; JANSSEN PMF; GOMMEREN W; WYNANTS J; PAUWELS PJ; JANSSEN PAJ
      INVITRO AND INVIVO RECEPTOR-BINDING AND EFFECTS ON MONOAMINE TURNOVERIN RAT-BRAIN REGIONS OF THE NOVEL ANTIPSYCHOTICS RISPERIDONE AND OCAPERIDONE

      Molecular pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 01:05:14